51607-16-0

Basic information

• Product Name: 2,3-O-ISOPROPYLIDENE-D-ERYTHRONOLACTONE
• Synonyms: 2,3-O-ISOPROPYLIDENE-D-ERYTHRONOLACTOL;(-)-2,3-O-ISOPROPYLIDENE-D-ERYTHRONO-LACTONE;2,3-O-ISOPROPYLIDENE-D-ERYTHRONOLACTONE
• CAS NO: 51607-16-0
• Molecular Formula: C₇H₁₂O₄
• Molecular Weight: 158.15
• Mol File: 51607-16-0.mol

Chemical Properties

• Melting Point: 67-69 °C(lit.)
• Boiling Point: 249.1±25.0 °C(Predicted)
• Appearance: /
• Density: 1.192±0.06 g/cm3(Predicted)
• PKA: 14.20±0.10(Predicted)
• CAS DataBase Reference: 2,3-O-ISOPROPYLIDENE-D-ERYTHRONOLACTONE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-O-ISOPROPYLIDENE-D-ERYTHRONOLACTONE(51607-16-0)
• EPA Substance Registry System: 2,3-O-ISOPROPYLIDENE-D-ERYTHRONOLACTONE(51607-16-0)

Safety Data

• Safety Statements: 22-24/25
• WGK Germany: 3
• Hazardous Substances Data: 51607-16-0(Hazardous Substances Data)

Usage

Physical State

White crystalline solid

Derivative

Isopropylidene derivative of D-erythronolactone

Usage

Starting material in synthesis of various compounds, including pharmaceuticals and agrochemicals

Role in Organic Synthesis

Acts as a protective group for the hydroxyl group in carbohydrates and related compounds

Biological Activity

Studied for potential inhibitory effects on enzymes
Investigated for potential therapeutic applications

Versatility

Serves as a key component in organic chemistry and pharmaceutical research

Upstream product

• 67-56-1 methanol 
• 93496-36-7 2,3-O-isopropylidene-β-D-erythrofuranosyl (Z)-3-acetyl-3-hydroxymethylacrylate 
• 93496-22-1 ethyl 2,3-O-isopropylidene-β-D-erythrofuranosyl 3-acetylfumarate 
• 64-17-5 ethanol 
• 93496-25-4 ethyl 2,3-O-isopropylidene-β-D-erythrofuranosyl 2-acetyl-3-methoxysuccinate 
• 583-50-6 D-erythrose 
• 67-64-1 acetone 
• 25581-41-3 D-erythronolactone acetonide 
• 24877-23-4 ethyl 5-(2',3'-O-isopropylidene-β-D-erythrofuranosyl)-2-methylfuran-3-carboxylate 
• 93496-23-2 1-((3aR,4R,6aR)-2,2-Dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl)-4-methyl-2,3,7-trioxa-bicyclo[2.2.1]hept-5-ene-5-carboxylic acid ethyl ester 
• 93253-48-6 3-hydroxymethyl-5-(2,3-O-isopropylidene-β-D-erythro-furanosyl)-2-methylfuran 
• 21335-55-7 n-pentenyl alcohol 

Downstream Products

• 127758-25-2 (4R,5S)-(2,2-dimethyl-5-vinyl-1,3-dioxolan-4-yl)methan-1-ol 
• 170555-75-6 (4R,5S)-4-(4-Methoxy-benzyloxymethyl)-2,2-dimethyl-5-vinyl-[1,3]dioxolane 
• 205866-41-7 (E)-(S)-3-(2-Benzyloxy-ethyl)-5-[(4S,5R)-5-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-pent-4-enoic acid methyl ester 
• 205866-18-8 (E)-(R)-3-(2-Benzyloxy-ethyl)-5-[(4S,5R)-5-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-pent-4-enoic acid methyl ester 
• 205866-17-7 (E)-(S)-5-Benzyloxy-1-[(4S,5R)-5-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-pent-2-en-1-ol 
• 205866-40-6 (Z)-(S)-5-Benzyloxy-1-[(4S,5R)-5-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-pent-2-en-1-ol 
• 205866-23-5 (3aR,8R,9R,9aR,9bS)-8-(2-Benzyloxy-ethyl)-9-hydroxy-2,2-dimethyl-hexahydro-[1,3]dioxolo[4,5-a]indolizin-6-one 
• 205866-22-4 (3aR,8R,9S,9aS,9bS)-8-(2-Benzyloxy-ethyl)-9-hydroxy-2,2-dimethyl-hexahydro-[1,3]dioxolo[4,5-a]indolizin-6-one 
• 205866-43-9 (E)-(S)-5-((4S,5R)-5-Azidomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-3-(2-benzyloxy-ethyl)-pent-4-enoic acid methyl ester 
• 205866-20-2 (E)-(R)-5-((4S,5R)-5-Azidomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-3-(2-benzyloxy-ethyl)-pent-4-enoic acid methyl ester 
• 205866-44-0 (S)-3-[3-((4R,5R)-5-Azidomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-oxiranyl]-5-benzyloxy-pentanoic acid methyl ester 
• 205866-21-3 (R)-3-[3-((4R,5R)-5-Azidomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-oxiranyl]-5-benzyloxy-pentanoic acid methyl ester 
• 205866-46-2 (3aR,8R,9R,9aR,9bS)-8-(2-Benzyloxy-ethyl)-2,2-dimethyl-octahydro-[1,3]dioxolo[4,5-a]indolizin-9-ol 
• 205866-24-6 (3aR,8S,9R,9aR,9bS)-8-(2-Benzyloxy-ethyl)-2,2-dimethyl-octahydro-[1,3]dioxolo[4,5-a]indolizin-9-ol 

Relevant articles and documents

Total synthesis of the resorcylic lactone-based kinase inhibitor L-783277

The total synthesis of the natural product L-783277 (1) has been accomplished based on the convergent assembly of building blocks 9, 10, and 14. Key steps are the Suzuki coupling of olefin 11 and aromatic building block 14, the Mitsunobu-based macrolac-to

Synthesis and mannosidase inhibitory activity of 6- and 7-substituted analogs of swainsonine

Swainsonine (1), an inhibitor of the important glycoprotein-processing enzyme Golgi α-mannosidase II, is a clinical candidate for cancer treatment. Analogs bearing substituents at C-6 and C-7 have been prepared and evaluated as inhibitors of α-mannosidase

Method for preparing swainsonine

(-)-Swainsonine may be prepared by (i) reacting a compound of formula (8): STR1 wherein OMs is methanesulfonyl with H 2 in the presence of Pd(OH) 2 followed by NaOMe, to obtain a compound of formula (9): STR2 and (ii) reducing the carbonyl group and hydrolyzing the ketal group in the compound of formula (9) to obtain (-)-swainsonine of formula (1): STR3

An enantiocontrolled synthesis of (-)-Swainsonine

(-)-Swainsonine 1, first isolated from the fungus Rhizoctonia leguminicola, has been sythesized enantioseletively. The key step was the stereoselective iodoamination of trichloro- acetimidate derived from (Z)- olefinic allylic alcohol 7.

Synthesis of sugars from substituted and unsubstituted arene diols

There are disclosed processes for the synthesis of substituted and unsubstituted arene diols useful in the further synthesis of sugars, sugar derivatives, chiral synthons or amino acids.

89. Deoxy-nitrosugars. 10th Communication. Synthesis of Isosteric Phosphonate Analogues of Ulose-1-Phosphates

A general approach to isosteric phosphonate analogues of ulose-1-phosphates is described.A base-catalysed chain elongation via a Michael addition of 1-deoxy-1-nitro-sugars 4, 8, and 16 to the vinylphosphonate 18 followed by hydrolysis of the nitro adducts

PHOTO-OXYGENATION OF GLYCOSYLFURANS. REARRANGEMENT OF C-GLYCOSYL INTO O-GLYCOSYL DERIVATIVES

Photo-oxygenation of 3-ethoxycarbonyl-5-(2,3-O-isopropylidene-β-D-erythrofuranosyl)-2-methylfuran and 3-hydroxymethyl-5-(2,3-O-isopropylidene-β-D-erythrofuranosyl)-2-methylfuran yields the corresponding endo-peroxydes which rearrange at room temperature into the O-glycosyl derivatives ethyl 2,3-O-isopropylidene-β-D-erythrofuranosyl 2-acetylfumarate and 2,3-O-isopropylidene-β-D-erythrofuranosyl 3-acetyl-3-hydroxymethylacrylate, respectively.The endo-peroxides can be reduced without rearrangement, yielding C-glycosyl derivatives.Alcoholysis of the O-glycosyl derivatives yields 2,3-O-isopropylidene-D-erythrose, dialkyl 2-acetyl-3-alkoxysuccinates, 4-ethoxycarbonyl-5-methoxy-5-methyl-2-oxo-2,5-dihydrofuran and 4-hydroxymethyl-5-methoxy-5-methyl-2-oxo-2,5-dihydrofuran.